← FDA DRUG APPROVALS

FDA NDA · NDA021387

PRAVIGARD PAC (COPACKAGED)

Sponsor: BRISTOL MYERS SQUIBB

APPLICATION
NDA021387
TYPE
NDA
ORIGINAL APPROVAL
2003-06-24
LATEST ACTION
2003-06-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PRAVIGARD PAC (COPACKAGED)Discontinued
ASPIRIN 81MG, PRAVASTATIN SODIUM 40MG · TABLET · ORAL
PRAVIGARD PAC (COPACKAGED)Discontinued
ASPIRIN 325MG, PRAVASTATIN SODIUM 40MG · TABLET · ORAL
PRAVIGARD PAC (COPACKAGED)Discontinued
ASPIRIN 81MG, PRAVASTATIN SODIUM 80MG · TABLET · ORAL
PRAVIGARD PAC (COPACKAGED)Discontinued
ASPIRIN 81MG, PRAVASTATIN SODIUM 20MG · TABLET · ORAL
PRAVIGARD PAC (COPACKAGED)Discontinued
ASPIRIN 325MG, PRAVASTATIN SODIUM 80MG · TABLET · ORAL
PRAVIGARD PAC (COPACKAGED)Discontinued
ASPIRIN 325MG, PRAVASTATIN SODIUM 20MG · TABLET · ORAL

Approval history

2003-06-24Type 4 - New Combination · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →